Clarice Reid | |
---|---|
Born | Clarice D. Reid 1931 (age 91–92) |
Alma mater | |
Known for |
|
Scientific career | |
Fields |
|
Institutions | Jewish Hospital, Cincinnati Children's Hospital, Cincinnati ContentsNational Heart, Lung and Blood Institute[1] |
Clarice D. Reid (born 1931) is an American pediatrician born in Birmingham, Alabama, who led the National Sickle Cell Disease Program at the U.S. National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health. [2] She went on to become the Director of Division of Blood Diseases and Resources at NHLBI. Reid was a member of the 1985-1986 Taskforce on Black and Minority Health. [3] She has also served as President Emeritus on the American Bridge Association's Education and Charitable Foundation, [4] and has scored a rare perfect bridge score. [5]
Clarice Reid was born in Birmingham, Alabama in 1931. [6] After attending a three-room elementary school in Birmingham, Alabama and the city's only high school for African American students, [7] Reid went on to follow in her father's footsteps by attending Talladega College in Alabama. [7] She began a course of study to become a medical technician before changing to medical school to become a physician at Meharry Medical College, in Nashville, Tennessee. [1] Her husband got a job in Cincinnati, so she completed her medical training at University of Cincinnati College of Medicine, [7] the third African American woman to gain an MD there. [1] She is a mother of four children. [7] In 1970, she moved to the DC area. [1]
Dr. Reid completed residencies at Jewish Hospital and Children's Hospital Medical Center in Cincinnati before opening a private practice as a pediatrician. [2] [8] She later became Director of Pediatric Education before chairing the Pediatric Department at Jewish Hospital. [1] After moving to the D.C. area, she first joined the National Center for Family Planning, Health Services and Mental Health Administration as a medical consultant before joining the National Sickle Cell Disease Program at the National Heart, Lung, and Blood Institute in 1973. [2]
Reid was a member of the 1985–86 Task Force on Black and Minority Health for the U.S. Government, [3] which was commissioned by Margaret Heckler and known as the "Heckler Report" and led to the establishment of the Office of Minority Health. In 1988, she retired as the director of the Division of Blood Diseases and Resources (DBDR), in the National Heart, Lung, and Blood Institute, after 26 years of federal service. [2] She facilitated collaboration between researchers in the sickle cell anemia community and advances in understanding sickle cell disease. [9]
Pulmonary heart disease, also known as cor pulmonale, is the enlargement and failure of the right ventricle of the heart as a response to increased vascular resistance or high blood pressure in the lungs.
The National Heart, Lung, and Blood Institute (NHLBI) is the third largest Institute of the National Institutes of Health, located in Bethesda, Maryland, United States. It is tasked with allocating about $3.6 billion in FY 2020 in tax revenue to advancing the understanding of the following issues: development and progression of disease, diagnosis of disease, treatment of disease, disease prevention, reduction of health care disparities within the American population, and advancing the effectiveness of the US medical system. NHLBI's Director is Gary H. Gibbons (2012–present).
Hemoglobin A (HbA), also known as adult hemoglobin, hemoglobin A1 or α2β2, is the most common human hemoglobin tetramer, accounting for over 97% of the total red blood cell hemoglobin. Hemoglobin is an oxygen-binding protein, found in erythrocytes, which transports oxygen from the lungs to the tissues. Hemoglobin A is the most common adult form of hemoglobin and exists as a tetramer containing two alpha subunits and two beta subunits (α2β2). Hemoglobin A2 (HbA2) is a less common adult form of hemoglobin and is composed of two alpha and two delta-globin subunits. This hemoglobin makes up 1-3% of hemoglobin in adults.
National Wear Red Day is a day in February when many people wear red to show their support for the awareness of heart disease.
Elizabeth Nabel is an American cardiologist and Executive Vice President of Strategy at ModeX Therapeutics and OPKO Health. Prior to this role, she served as President of Brigham Health and its Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, and Director of the NIH's National Heart, Lung, and Blood Institute.
Sickle cell disease (SCD), one of the hemoglobinopathies, is a group of blood disorders typically inherited. The most common type is known as sickle cell anaemia. It results in an abnormality in the oxygen-carrying protein haemoglobin found in red blood cells. This leads to a rigid, sickle-like shape under certain circumstances. Problems in sickle cell disease typically begin around 5 to 6 months of age. A number of health problems may develop, such as attacks of pain, anemia, swelling in the hands and feet, bacterial infections, and stroke. Long-term pain may develop as people get older. The average life expectancy in the developed world is 40 to 60 years.
Susan Shurin is a senior adviser at the National Cancer Institute. From 2006–2014, she served as Deputy and Acting Director of the National Heart, Lung, and Blood Institute at the National Institutes of Health.
Marilyn Hughes Gaston is a physician and researcher. She was the first black woman to direct the Bureau of Primary Health Care in the U.S. Health Resources and Services Administration. She is most famous for her work studying sickle cell disease (SCD).
Vanessa Northington Gamble is a physician who chaired the Tuskegee Syphilis Study Legacy Committee in 1996.
Martha Vaughan was an American biochemist at the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) in Bethesda, Maryland. She holds the title of emeritus scientist in the Laboratory of Metabolic Regulation and previously served as chief of NHLBI’s Laboratory of Cellular Metabolism. At the NIH, much of her work has focused on cell signaling, cellular regulation, lipid metabolism, and the identification of key proteins associated with cholera toxin and pertussis toxin. Vaughan first came to the NIH in the agency’s fledgling National Heart Institute, now NHLBI, and with the title of senior assistant surgeon worked on protein synthesis in the Building 3 laboratory of biochemist and public scientist Christian B. Anfinsen, Ph.D., who went on to share the 1972 Nobel Prize in Chemistry
Clare M. Waterman is a cell biologist who has worked on understanding the role of the cytoskeleton in cell migration. Waterman is a Distinguished Investigator, Chief of the Laboratory of Cell and Tissue Morphodynamics, and Director of the Cell and Developmental Biology Center at the National Heart, Lung, and Blood Institute (NHLBI), in the National Institutes of Health (NIH) in Bethesda MD, USA. Waterman has received several awards and honors, including the Sackler International prize in Biophysics, the NIH Director’s Pioneer Award, and the Arthur S. Flemming Award for Public Service. In 2018, she was elected to the National Academy of Sciences. She currently serves on the editorial boards of eLife, Current Biology and Journal of Microscopy.
James M. Anderson is an American Professor of Medicine and Cell Biology and is a Chief of Section of Digestive Diseases at the Yale School of Medicine. Anderson is also a director of the Division of Program Coordination, Planning, and Strategic Initiatives at the National Institutes of Health.
Stephanie L. Constant is an American immunologist and science administrator. She was an associate professor at George Washington University and a scientific review officer at National Heart, Lung, and Blood Institute before becoming chief of the National Institute of General Medical Sciences Office of Scientific Review in 2017.
Swee Lay Thein is a Malaysian haematologist and physician-scientist who is Senior Investigator at the National Institutes of Health. She works on the pathophysiology of haemoglobin disorders including sickle cell disease and thalassemia.
Jodi Beth Black is an American microbiologist and research administrator serving as deputy director of the Office of Extramural Research at the National Institutes of Health. She was previously the director and vice president of research administration at the Translational Genomics Research Institute and the acting director of the division of extramural activities at the National Heart, Lung, and Blood Institute.
Joyonna Gamble-George is an American neuroscientist, innovator, and entrepreneur known for her research with the endocannabinoid system in stress-induced maladaptations of the brain. She is an Adjunct Professor at St. Petersburg College, Florida.
Michael S. Lauer is an American cardiologist and physician-scientist. He is the deputy director for extramural research at the National Institutes of Health (NIH).
Courtney D. Fitzhugh is an American hematologist-oncologist and scientist. She is a clinical researcher and head of the laboratory of early sickle cell mortality prevention at the National Heart, Lung, and Blood Institute.
Cynthia Dunbar is an American scientist and hematologist at the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). She is the Branch Chief of the Translational Stem Cell Biology Branch.
Julie Ann Panepinto is an American pediatric hematologist-oncologist and physician-scientist. She specializes in health outcomes research and sickle cell disease. Panepinto became the acting director of the division of blood diseases and resources at the National Heart, Lung, and Blood Institute in 2022. She was a professor of pediatrics and hematology at the Medical College of Wisconsin.